← Back to Search

Diabetes Prevention & Education for Prediabetes

N/A
Recruiting
Research Sponsored by University of Maryland, Baltimore
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Qualify for DPP with a diagnosis of pre-diabetes and elevated BMI (≥25 kg/m2 , ≥23kg/m2 if Asian)
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up end of calendar year enrollment, yearly for 3 years
Awards & highlights

Study Summary

This trial aims to reduce risk of type 2 diabetes in people with pre-diabetes by increasing access to lifestyle interventions. We will also study changes in body fat & liver fat in those who complete the program.

Who is the study for?
This trial is for adults with prediabetes, obesity, or type 2 diabetes who want to prevent or manage their condition. Participants should have a BMI of at least 25 (or 23 if Asian) indicating overweight status. Those with normal blood sugar levels are not eligible.Check my eligibility
What is being tested?
The trial tests the Diabetes Prevention Program (DPP) and Diabetes Self-Management Training (DSMT). It aims to see if these programs can reduce the risk of developing type 2 diabetes and improve body composition and liver health in participants.See study design
What are the potential side effects?
As DPP and DSMT are educational programs focusing on lifestyle changes rather than medications, they typically do not have direct side effects like drugs do. However, changing diet and exercise might cause temporary discomfort.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am pre-diabetic with a BMI of 25 or higher, or 23 if I'm Asian.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~end of calendar year enrollment, yearly for 3 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and end of calendar year enrollment, yearly for 3 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in body weight for DPP participants
Enrollees into DPP and DSMT
Secondary outcome measures
Change in diabetes control for DSMT participants
change in body composition in DPP participants
change in liver elastography in DPP participants

Trial Design

1Treatment groups
Experimental Treatment
Group I: InterventionExperimental Treatment1 Intervention
All subjects participating in the diabetes prevention program will be offered body composition analysis and liver fat analysis, before, during, and after the lifestyle intervention

Find a Location

Who is running the clinical trial?

University of Maryland, BaltimoreLead Sponsor
688 Previous Clinical Trials
354,656 Total Patients Enrolled

Media Library

Diabetes Prevention Program (DPP) Clinical Trial Eligibility Overview. Trial Name: NCT05769127 — N/A
Fatty Liver Disease Research Study Groups: Intervention
Fatty Liver Disease Clinical Trial 2023: Diabetes Prevention Program (DPP) Highlights & Side Effects. Trial Name: NCT05769127 — N/A
Diabetes Prevention Program (DPP) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05769127 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are individuals aged 35 or older being admitted to this investigation?

"This clinical trial is recruiting participants that are of legal age or above and have not reached their 89th year."

Answered by AI

Do I qualify to take part in this research?

"This clinical trial seeks to involve 20,000 individuals with fatty liver disease between the ages of 18 and 89. The most essential inclusion criterion is that patients must have type 2 diabetes for DSMT (Diabetes Self-Management Training)."

Answered by AI

Are participants still being accepted into this clinical investigation?

"According to the data on clinicaltrials.gov, this investigation is not looking for additional participants at present. The study was first released in April 1st 2023 and updated lastly on March 2nd 2023. Although it is not recruiting presently, there are 1762 other medical trials actively searching for patients right now."

Answered by AI

Who else is applying?

What site did they apply to?
University of Maryland Center for Diabetes and Endocrinology
What portion of applicants met pre-screening criteria?
Met criteria
Did not meet criteria

Why did patients apply to this trial?

I am hoping to have success with guidance in lifestyle changes.
PatientReceived 1 prior treatment
Recent research and studies
clinicaltrials.govStudy
Diabetes Prevention and Education
KASHIF M MUNIR 2023. "Diabetes Prevention and Education". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05769127.
All > Fatty Liver Disease
~12500 spots leftby Dec 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top